The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring the “obesity paradox” in triple negative breast cancer patients receiving neoadjuvant immunotherapy.
 
Ashley Schreier
No Relationships to Disclose
 
Aaron Holmes
No Relationships to Disclose
 
Steven Chen
No Relationships to Disclose
 
Roberta Zappasodi
Consulting or Advisory Role - Daiichi Sankyo; IFLI; iTEOS Therapeutics
Research Funding - AstraZeneca; BMS GmbH & Co. KG
Patents, Royalties, Other Intellectual Property - Agenus (Inst); Memorial Sloan-Kettering Cancer Center (Inst); Weill Cornell Medical College (Inst)
 
Eleni Andreopoulou
No Relationships to Disclose
 
Xi Zhou
No Relationships to Disclose
 
Patrick Kennedy
No Relationships to Disclose
 
Evelyn Taiwo
No Relationships to Disclose
 
Lauren Elreda
No Relationships to Disclose
 
Pooja Murthy
No Relationships to Disclose
 
Laura Munoz Arcos
No Relationships to Disclose
 
Tessa Cigler
Leadership - Atossa Therapeutics
Consulting or Advisory Role - Curio Science; Lumanity; MDoutlook; Targeted Oncology
Travel, Accommodations, Expenses - Atossa Therapeutics
 
Massimo Cristofanilli
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; Celcuity; Lilly; Menarini; Olaris; Sermonix Pharmaceuticals; Syantra
Research Funding - Angle; AstraZeneca; Lilly; Menarini Silicon Biosystems; Merck
 
Alan Astrow
No Relationships to Disclose
 
Vered Stearns
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); QUE Oncology (Inst)
Other Relationship - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine (Inst)